A Maturing Market
Investment management and mutual funds are showing more interest in the genomics industry, according to a recent report, diminishing some companies’ reliance on venture capital and indicating a shift to mainstream. Shown here: top genomics investors, by total share price value (in millions)
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
